Important Information Regarding Vyzulta

Posted in Latest News on March 16, 2018.

During the March 9, 2018 Board of Optometry meeting, the board approved for addition to Rule 64B13-18.002 Formulary of Topical Ocular Pharmaceutical Agents, Vyzulta (latanoprostene bunod ophthalmic solution) 0.024%.

Important note, Vyzulta, at this time, cannot be prescribed by certified Optometrists in Florida until the rule has been approved. Once the rule has gone through the approval process, notice will be provided on this site, and at that time Vyzulta may be prescribed by certified optometrists.

 



More Latest News

Take Control of Controlled Substances
May 7, 2018

Click Here to be in the know on how Florida’s new legislation on controlled substances affects you Continue reading


Opioid Epidemic in Florida
April 17, 2018

In an effort to combat the national opioid epidemic in Florida, in March 2018 Governor Rick Scott signed HB 21 creating new limits on schedule II prescriptions for pain medication. Continue reading